← Leaderboards
Conor Lee Evans
Massachusetts General Hospital
$6,486,541
Attributed
$8,449,461
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,960,338 · 5
FDA$1,489,123 · 1
By mechanism
R01$3,925,840 · 2
DP2$2,655,000 · 1
U01$1,489,123 · 1
R21$306,560 · 1
F32$72,938 · 1
Top collaborators
- Aaron D Aguirre2 shared
- Amanda Elizabeth Winkler1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Joseph F Cotten$6,246,440
- Dennis Brown$23,445,948
- Teodor G. Paunescu$722,605
- Loren M Frank$13,127,500
- Aaron D Aguirre$5,111,417
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseSamplingTechnologyLifeMonitorResolutionMalignant NeoplasmsDesignTumorImageryImageMeasurementCollaborationsMalignant Neoplasm Of OvaryStagingProgramsDevicesPublic Health RelevanceMicroscopicHourPhotochemotherapyInnovationAnimal ModelCessation Of Life
Grant awards (13)
Noninvasive Neonatal Blood Gas Monitoring$2,453,962
R01 · FY2025 · HD · contact PI
Blood Gas Analysis Without the Laboratory$735,939
R01 · FY2025 · HL · contact PI
Blood Gas Analysis Without the Laboratory$735,939
R01 · FY2024 · HL · contact PI
Pharmacokinetic Tomography for the Measurement of Topical Drug Product Bioequivalence$247,926
U01 · FY2023 · FD · contact PI
Pharmacokinetic Tomography for the Measurement of Topical Drug Product Bioequivalence$247,140
U01 · FY2022 · FD · contact PI
Pharmacokinetic Tomography for the Measurement of Topical Drug Product Bioequivalence$247,181
U01 · FY2021 · FD · contact PI
Pharmacokinetic Tomography for the Measurement of Topical Drug Product Bioequivalence$247,507
U01 · FY2020 · FD · contact PI
Pharmacokinetic Tomography for the Measurement of Topical Drug Product Bioequivalence$499,369
U01 · FY2019 · FD · contact PI
Hyperspectral and Structural Microscopy Platform for Therapy of Resistant Cancer$132,487
R21 · FY2012 · CA · contact PI
Hyperspectral and Structural Microscopy Platform for Therapy of Resistant Cancer$174,073
R21 · FY2011 · CA · contact PI
Imaging and Overcoming Hypoxia-Induced Resistance in Metastatic Ovarian Cancer$2,655,000
DP2 · FY2010 · OD · contact PI
Multimodality Microendoscope for Metastatic Ovarian Cancer Detection & Treatment$25,728
F32 · FY2010 · CA · contact PI
Multimodality Microendoscope for Metastatic Ovarian Cancer Detection & Treatment$47,210
F32 · FY2009 · CA · contact PI